EPO and liver dysplastic nodule: In diabetic retinas, EPO protects retinal cells by upregulating ZnT8 via ERK pathway activation and HIF-1α expression inhibition [10], and EPO may slow progression of diabetic nephropathy (DN) [11, 12].